Skip to main content
SpringerLink
Log in

Epidemiology and Control of Multiresistant Enterococci

  • Section 3: Epidemiology, Control and Treatment of Multiresistant Organisms: Pneumococci, Enterococci and MRSA
  • Short Communication
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schaberg DR, Culver DH, Gaynes RP. Trends in the microbial etiology of nosocomial infection. Am J Med 1991; Suppl. 3B: 72–5

    Article  Google Scholar 

  2. Moellering Jr RC. The Garrod Lecture — The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1991; 28: 1–12.

    Article  PubMed  Google Scholar 

  3. Murray BE. β-Lactamase producing enterococci. Antimicrob Agents Chemother 1992; 36: 2355–9.

    Article  PubMed  CAS  Google Scholar 

  4. Fontana R, Aldegheri M, Ligozzi M, et al. Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1994; 38: 1980–3.

    Article  PubMed  CAS  Google Scholar 

  5. Leclercq R, Dutka-Malen S, Brisson-Noël A, et al. Resistance of enterococci to aminoglycosides and glycopeptides. Clin Infect Dis 1992; 15: 495–501.

    Article  PubMed  CAS  Google Scholar 

  6. Murray BE. The life and times of the Enterococcus. Clin Microb Rev 1990; 3: 46–65.

    CAS  Google Scholar 

  7. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37: 1563–71.

    Article  PubMed  CAS  Google Scholar 

  8. Centers for Disease Control. Nosocomial enterococci resistant to vancomycin: United States, 1989–1993: National Nosocomial Infection Surveillance. MMWR Morb Mortal Wkly Rep 1993; 42: 597–9.

    Google Scholar 

  9. Vercauteren E, Leclercq R, Goossens H. Belgian surveillance study of enterococcal susceptibility patterns [abstract E10]. 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1994 Oct 4–7: Orlando, USA

  10. Jones RN, Sader HS, Erwin ME, et al. Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Diagn Microbiol Infect Dis 1995; 21: 85–93.

    Article  PubMed  CAS  Google Scholar 

  11. Zervos MJ, Kauffman CA, Therasse PM, et al. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med 1987; 106: 687–91.

    PubMed  CAS  Google Scholar 

  12. Korten V, Murray BE. The nosocomial transmission of enterococci. Curr Opin Infect Dis 1993; 6: 498–505.

    Article  Google Scholar 

  13. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105–13.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept of Bacteriology, CHU Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France

    Roland Leclercq

Authors
  1. Roland Leclercq
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leclercq, R. Epidemiology and Control of Multiresistant Enterococci. Drugs 52 (Suppl 2), 47–49 (1996). https://doi.org/10.2165/00003495-199600522-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600522-00010

Keywords

Search

Navigation